Published in Microb Cell Fact on April 08, 2016
Functional inclusion bodies produced in the yeast Pichia pastoris. Microb Cell Fact (2016) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol (2005) 2.41
Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem (2002) 2.06
Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself. Circ Res (2005) 1.91
Unscrambling an egg: protein disaggregation by AAA+ proteins. Microb Cell Fact (2004) 1.19
Nanotechnology, bionanotechnology and microbial cell factories. Microb Cell Fact (2010) 1.09
"Dirty little secrets"--endotoxin contamination of recombinant proteins. Immunol Lett (2006) 1.06
Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics. Biotechnol Adv (2012) 1.05
Single amino acid substitutions in either YhjD or MsbA confer viability to 3-deoxy-d-manno-oct-2-ulosonic acid-depleted Escherichia coli. Mol Microbiol (2007) 0.98
The metabolic potential of Escherichia coli BL21 in defined and rich medium. Microb Cell Fact (2014) 0.97
Nanostructured bacterial materials for innovative medicines. Trends Microbiol (2010) 0.95
Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli. J Biotechnol (2006) 0.94
Recombinant pharmaceuticals from microbial cells: a 2015 update. Microb Cell Fact (2016) 0.93
Detoxifying Escherichia coli for endotoxin-free production of recombinant proteins. Microb Cell Fact (2015) 0.90
Production of functional inclusion bodies in endotoxin-free Escherichia coli. Appl Microbiol Biotechnol (2014) 0.85
New challenges and opportunities for industrial biotechnology. Microb Cell Fact (2012) 0.84
Integrating mechanical and biological control of cell proliferation through bioinspired multieffector materials. Nanomedicine (Lond) (2015) 0.82
Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles. Int J Nanomedicine (2012) 0.81
Advances and needs for endotoxin-free production strains. Appl Microbiol Biotechnol (2015) 0.80
Microbial biofabrication for nanomedicine: biomaterials, nanoparticles and beyond. Nanomedicine (Lond) (2013) 0.79
Protein polymer hydrogels: effects of endotoxin on biocompatibility. J Biomater Appl (2012) 0.78
Bottom-Up Instructive Quality Control in the Biofabrication of Smart Protein Materials. Adv Mater (2015) 0.78
In vivo architectonic stability of fully de novo designed protein-only nanoparticles. ACS Nano (2014) 0.78
Targeting glioblastoma via intranasal administration of Ff bacteriophages. Front Microbiol (2015) 0.77
Non-amyloidogenic peptide tags for the regulatable self-assembling of protein-only nanoparticles. Biomaterials (2012) 0.77